Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 2024 Dec 16;134(24):e189439. doi: 10.1172/JCI189439

CRISPR/Cas13d targeting suppresses repeat-associated non-AUG translation of C9orf72 hexanucleotide repeat RNA

Honghe Liu, Xiao-Feng Zhao, Yu-Ning Lu, Lindsey R Hayes, Jiou Wang
PMCID: PMC11645136  PMID: 39680464

Original citation J Clin Invest. 2024;134(21):e179016. https://doi.org/10.1172/JCI179016

Citation for this corrigendum: J Clin Invest. 2024;134(24):e189439. https://doi.org/10.1172/JCI189439

During the preparation of this manuscript, an involved patent was mistakenly omitted from the conflict-of-interest statement. The correct statement is below. The HTML and PDF versions of the manuscript have been updated.

HL and JW are listed as inventors on a patent application (application number: 63313150) filed by Johns Hopkins University on technologies related to this manuscript.

Version 1. 12/16/2024

Electronic publication

Footnotes

Contributor Information

Honghe Liu, Email: rivulet86@gmail.com.

Xiao-Feng Zhao, Email: xzhao64@jhu.edu.

Yu-Ning Lu, Email: a22755457@gmail.com.

Lindsey R. Hayes, Email: lhayes@jhmi.edu.

Jiou Wang, Email: jiouw@jhu.edu.


Articles from The Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES